top of page

Search Results

Results found for "A3 adenosine receptor"

  • Dr. Alexander S. Hauser | Dr. GPCR Ecosystem

    pharmacology, and pharmacoepidemiology with innovative computational methods to gain novel insights into receptor identify human signaling systems and thereby discovered endogenous peptides activating several orphan receptors

  • When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem

    journey highlights the transition from general drug development to a deep dive into G protein-coupled receptors at the University of Michigan, Ben focuses on positive allosteric modulators (PAMs) targeting opioid receptors thiazolidines and xanthinediones, Ben is helping define how structurally different PAMs may act on similar receptor from the University of Minnesota in 2022, studying the pharmacokinetics and pharmacodynamics of NMDA receptor determining the mechanisms of action of a series of positive allosteric modulators of the mu-opioid receptor

  • Session VII | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    Blanco Redondo Abstract "The Drosophila genome contains five loci encoding adhesion G-protein coupled receptors remoulade (remo) gene is a homologue of the vertebrate aGPCR ADGRA family, sharing the same overall receptor We found that the receptor is cleaved despite the lack of a consensus GPS sequence. Langenhan where I am studying and characterizing newly generated adhesion GPCR receptors in Drosophila

  • Dr. Fiona Marshall | Dr. GPCR Ecosystem

    episode Fiona Marshall got fascinated with GPCRs after attending a lecture on how the beta-adrenergic receptor biology, Fiona published the first description of the cloning and structural requirements of the GABAB receptor

  • Dr. Hannes Schihada | Dr. GPCR Ecosystem

    Hannes Schihada Following studies in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology I spent 2 1/2 years in his lab and developed novel conformational sensors for these intriguing receptors

  • Dylan Eiger | Dr. GPCR Ecosystem

    focuses on the mechanisms underlying biased signaling at GPCRs, specifically, the role of differential receptor He primarily studies the chemokine receptor CXCR3 as it has three naturally occurring ligands and thus

  • Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    Flash Presentations Health and Disease, Metabolism, Nervous System, Proteomics and Transcriptomics, Receptor Adhesion GPCR Signaling In Vivo Lara-Sophie Brodmerkel Novel isoforms of adhesion G protein coupled receptor Recent studies implicate the dysregulation of adhesion G-Protein coupled receptors (GPCRs) in GBM development However, the physiological relevance of flap flexibility on receptor activation and signaling remains The cleaved BAI1 isoform has a 19 amino acid extracellular stalk that can serve as a receptor agonist

  • Dr. Mark Connor | Dr. GPCR Ecosystem

    Ph.D. from Department of Pharmacology, University of Washington (1992, mentor Charley Chavkin , sigma receptors Focus on study of drugs and toxins on GPCR (opioid, cannabinoid receptor) and ion channel (K, Ca, TRP

  • Dr. Nicola J. Smith | Dr. GPCR Ecosystem

    developing a powerful new computational tool for identifying ‘surrogate’ ligands (borrowed from other receptors this expertise to establish a research program that takes orphan GPCRs from ‘locked’, inaccessible receptors

  • Dr. Sai Prasad Pydi | Dr. GPCR Ecosystem

    obtained his Ph.D. from the University of Manitoba – Canada, where he was introduced to G protein-coupled receptors His doctoral research focused on the structural and functional characterization of bitter taste receptors

  • Dr. Aylin Hanyaloglu | Dr. GPCR Ecosystem

    Mark von Zastrow where she identified novel core cellular machinery critical for G protein-coupled receptor cell biological mechanisms regulating GPCR activity, including spatial control of GPCR signaling and receptor

  • Pharmacological and Genetic Preclinical Models of Ghrelin Receptor Functional Selectivity to Investigate Metabolic Disease Pathophysiology

    Sponsors GPCR Retreat Program < Back to schedule Pharmacological and Genetic Preclinical Models of Ghrelin Receptor

  • Dr. Aurélien Rizk | Dr. GPCR Ecosystem

    Aurelien Rizk shared that he had always focused on GPCRs but had also worked on other types of receptors Yamina Berchiche had a detailed conversation about the intricacies of cell signaling and chemokine receptors They validated their technology and made collaborations for expertise on chemokine receptors. Therapeutic Effect and Receptor Interactions Aurelien Rizk and Yamina had a detailed discussion about They emphasized the need to quantify the dynamics of the pathways and the residence time of the receptor

  • Biochemical Mechanisms Underlying Location Bias in GPCR Signaling

    approaches to quantify ligand bias and the identification of ACKR3 as an endogenously beta-arrestin-biased receptor His group and others have shown that many of these ligands act as biased agonists for the same receptor

  • Dr. Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore | Dr. GPCR Ecosystem

    Neuroscience at the University of Ottawa as a Postdoctoral Fellow to explore novel G protein-coupled receptor at The Rockefeller University, where she study’s the signaling and degradation of G protein-coupled receptors to understand the mechanism by which a new class of biased allosteric modulators for the neurotensin receptor

  • Dr. Thomas P. Sakmar | Dr. GPCR Ecosystem

    also went on to discover a “counterion switch” in visual pigments and to develop strategies to assay receptor-G-protein from this work, such as the concept of “functional micro-domains” and the “helix movement model of receptor , the parallel development of bioorthogonal labeling strategies to couple fluorophores to expressed receptors

  • Dr. Raul Gainetdinov | Dr. GPCR Ecosystem

    Since 2013, he has been elected Chair of the subcommittee for the Dopamine receptors of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification

  • Dr. Yamina Berchiche | Dr. GPCR Ecosystem

    G protein-coupled receptors (GPCRs) mediate a vast variety of critical biological processes and provide for quantitative, and multi‐scale integration of these amounts of data to gain novel insights into receptor

  • Dr. Nariman Balenga | Dr. GPCR Ecosystem

    and received my Ph.D. in Molecular Medicine in 2010 after studying the orphan atypical cannabinoid receptor I studied the function of RGS5, calcium-sensing receptor, and an orphan adhesion GPCR, GPR64/ADGRG2 in

  • Genetic Deletion of Atypical VGLUT3 Rescues Huntington’s Disease Phenotype and Neurodegeneration in zQ175 Mice

    / 2:10 PM About Karim Ibrahim "A postdoctoral researcher, interested in studying G-protein coupled receptors

  • "Have a nice weekend, and I'll see you tomorrow!": RAMP-interacting GPCR Pathways

    With a special emphasis on G protein coupled receptors and receptor activity modifying proteins in vascular

  • Dr. Kathleen Caron | Dr. GPCR Ecosystem

    With a special emphasis on G protein coupled receptors and receptor activity modifying proteins in vascular

  • Dr. Timo De Groof | Dr. GPCR Ecosystem

    within the research group and used this platform to develop nanobodies targeting viral G protein-coupled receptors with a special focus on the human cytomegalovirus-encoded chemokine receptor US28.

  • Xylazine, Fentanyl, and the Fight for Breath with Catherine Demery | Dr. GPCR Ecosystem

    sedative that prolongs exhalation and induces bradycardia—acting through alpha-2 adrenergic, not opioid, receptors investigates how fentanyl and xylazine shut down breathing through different mechanisms—work that blends receptor Listen now and see how one scientist is turning molecules into a mission, bridging the gap between receptor

  • Dr. GPCR Board | Dr. GPCR Ecosystem

    GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the thorough and mechanistic understanding of processes that control cell signaling by protease-activated receptors Her laboratory is the recognized expert on protease-activated receptors, particularly PAR1, and over

  • Dr. JoAnn Trejo | Dr. GPCR Ecosystem

    thorough and mechanistic understanding of processes that control cell signaling by protease-activated receptors Her laboratory is the recognized expert on protease-activated receptors, particularly PAR1, and over

  • Dr. Josephine (Pina) Cardarelli | Dr. GPCR Ecosystem

    discover and develop highly effective cancer therapeutics by targeting heteromers of G protein-coupled receptors At Medarex, she initiated and identified the lead mAb for the type I interferon-alpha receptor project

  • Dr. Michael Feigin | Dr. GPCR Ecosystem

    Craig Malbon at SUNY Stony Brook studying the role of G-protein coupled receptors (GPCRs) and their regulators discussed his research on cell polarity and its role in cancer progression, his work on G-protein coupled receptors they face in studying GPCRs due to their low expression levels and the difficulty of localizing these receptors He also discussed his work on G-protein coupled receptors (GPCRs) in breast cancer, identifying GPR161 they face in studying GPCRs due to their low expression levels and the difficulty of localizing these receptors

  • You never know where your GPCR takes you with Dr. Brian Hudson | Dr. GPCR Ecosystem

    years of experience in GPCR, primarily focused on drug discovery and developing new tools to study this receptor

  • Robert Laprairie | Dr. GPCR Ecosystem

    The focus of his research is the molecular pharmacology of cannabinoids and cannabinoid receptors.

bottom of page